Agios Pharmaceuticals | AGIO - Activos Circulantes





Activos Circulantes Cambio Fecha
AbbVie USD 37.48B 3.81B 2026-09
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.36B 598M 2026-09
Arrowhead Research USD 1.67B 168.34M 2026-06
Astellas Pharma JPY 1.44T 41.22B 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Daiichi Sankyo JPY 2.38T 150.33B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Exelixis USD 1.32B 70.8M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Merck USD 38.94B 2.26B 2026-09
Moderna USD 5.82B 45M 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 28.75B 1.4B 2026-09
Novartis USD 28.75B 2.14B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09